Alfonso Caro

Alfonso Caro

Auto-generated profile, based on publicly available information

Alfonso Caro

Translational Genetics Research Group, Instituto de Investigación

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
AHAna Victoria Marco Hernández
Ana Victoria Marco Hernández
ACAlfonso Caro
Alfonso Caro
AFAlejandro Montoya Filardi
Alejandro Montoya Filardi
MVMiguel Tomás Vila
Miguel Tomás Vila
SMSandra Monfort
Sandra Monfort
FMFrancisco Martinez
Francisco Martinez

8 July 2024 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Open access
MFMaría Alcázar Fabra
María Alcázar Fabra
APAbraham J. Paredes-Fuentes
Abraham J. Paredes-Fuentes
MCManuel Torralba Carnerero
Manuel Torralba Carnerero
DFDaniel José Moreno Fernández-Ayala
Daniel José Moreno Fernández-Ayala
ALAntonio Arroyo Luque
Antonio Arroyo Luque
Carlos Santos-OcañaCarlos Santos-Ocaña
Carlos Santos-Ocaña
The protein encoded by COQ7 is required for CoQ10 synthesis in humans, hydroxylating 3‐demethoxyubiquinol (DMQ10) in the second to last steps of the pathway. COQ7 mutations lead to a primary CoQ10 deficiency syndrome associated with a pleiotropic neurological disorder. This study shows the clinical, physiological, and molecular characterization of four new cases of CoQ10 primary deficiency caused by five mutations in COQ7, three of which have not yet been described, inducing mitochondrial dysfunction in all patients. However, the specific combination of the identified variants in each patient generated precise pathophysiological and molecular alterations in fibroblasts, which would explain the differential in vitro response to supplementation therapy. Our results suggest that COQ7 dysfunction could be caused by specific structural changes that affect the interaction with COQ9 required for the DMQ10 presentation to COQ7, the substrate access to the active site, and the maintenance of the active site structure. Remarkably, patients' fibroblasts share transcriptional remodeling, supporting a modification of energy metabolism towards glycolysis, which could be an adaptive mechanism against CoQ10 deficiency. However, transcriptional analysis of mitochondria‐associated pathways showed distinct and dramatic differences between patient fibroblasts, which correlated with the extent of pathophysiological and neurological alterations observed in the probands. Overall, this study suggests that the combination of precise genetic diagnostics and the availability of new structural models of human proteins could help explain the origin of phenotypic pleiotropy observed in some genetic diseases and the different responses to available therapies.

31 March 2018 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
MAMaria Isabel Alvarez-Mora
Maria Isabel Alvarez-Mora
IMIrene Madrigal
Irene Madrigal
FMFrancisco Martinez
Francisco Martinez
MTMaria-Isabel Tejada
Maria-Isabel Tejada
SISilvia Izquierdo
Silvia Izquierdo
MMM. Milà
M. Milà

7 July 2025 in Amyloid
Verified
Journal Article
Closed access
MDMarta Domínguez-Martínez
Marta Domínguez-Martínez
ACAlfonso Caro-Llopis
Alfonso Caro-Llopis
CMCarla Martín-Grau
Carla Martín-Grau
MRMónica Roselló
Mónica Roselló
SOSilvestre Oltra
Silvestre Oltra
COCarmen Orellana
Carmen Orellana
Hereditary transthyretin amyloidosis (ATTRv) is a rare, progressive disorder caused by TTR gene variants, leading to amyloid fibril deposition and clinical manifestations like cardiomyopathy and polyneuropathy. National data for Spain are scarce, despite known high-prevalence areas such as Majorca. This multicentric, retrospective study analysed 4,526 individuals from 48/52 Spanish regions between 2015 and 2024, including 3,960 index cases and 566 at-risk relatives. Genetic testing was performed to identify pathogenic TTR variants. Among 393 carriers of pathogenic variants, the most prevalent were p.Val50Met (64.1%) and p.Val142Ile (29.5%). Regional prevalence varied, with new high-prevalence areas identified, including Cádiz, Castellón, Ciudad Real, Huelva, Valencia and Zamora. A novel variant of unknown clinical significance, p.Ser137Thr, was found in two unrelated cases. Genotype-phenotype correlations showed p.Val50Met is linked to neurological phenotypes, while p.Val142Ile is associated with cardiac manifestations. A male predominance was observed in index cases, while the sex ratio in carrier relatives was similar to the general population. This is the largest nationwide study of ATTRv in Spain, providing key insights into its genetic landscape. The findings suggest migratory factors may influence variant distribution, emphasising the importance of genetic screening for early diagnosis and management.